Clinical Trial Update: Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating imaging of brain tumor hypoxia using Fluoromisonidazole and FDG; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer

Drugs mentioned

• Fluorodeoxyglucose (Fluorodeoxyglucose)
• Fluoromisonidazole (Fluoromisonidazole)

Snippet

Sponsor: University of Utah | Conditions: Brain Cancer | Phase 1 | Status: TERMINATED